Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01538264 · ClinicalTrials.gov registry record
Blood Flow MRI for Monitoring Brain Tumors
A clinical trial of Brain Tumors, sponsored by Beth Israel Deaconess Medical Center.
- Active
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT01538264: Active study of Brain Tumors, sponsored by Beth Israel Deaconess Medical Center.
NCT01538264 is a study of Brain Tumors that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 125 participants, below the 6,330-participant average among 10 other Brain Tumors trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01538264, a study of Brain Tumors, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are studying the use of an advanced magnetic resonance imaging (MRI) technique for measuring blood flow into brain tumors. This technique does not use radioactive tracers, and it can provide high quality images that can be obtained in a standard MRI scanner.
Conditions Studied
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2006-06 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT01538264 still lists
NCT01538264 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 6,330-participant average among 10 other Brain Tumors trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Brain Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT01538264 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01538264 about?
NCT01538264 is a clinical study titled "Blood Flow MRI for Monitoring Brain Tumors". The investigators are studying the use of an advanced magnetic resonance imaging (MRI) technique for measuring blood flow into brain tumors. This technique does not use radioactive tracers, and it can provide high quality images that can be obtained in a standard MRI scanner.
What is the current status of trial NCT01538264?
This trial is currently active not recruiting. The enrollment target is 125 participants. The study started on 2006-06. Estimated completion is 2025-12-31.
What conditions does trial NCT01538264 study?
This clinical trial studies the following conditions: Brain Tumors.
Who is sponsoring clinical trial NCT01538264?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01538264 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01538264's enrollment target sits among peer trials
125 5th of 10 higher than 6 of 10 other Brain Tumors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Tumors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Florida Center for Brain Tumor Research
RECRUITING
-
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
ACTIVE NOT RECRUITING
-
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
ACTIVE NOT RECRUITING
-
ALA-induced PpIX Fluorescence During Brain Tumor Resection
ACTIVE NOT RECRUITING · Phase 1
-
Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors
COMPLETED · NA
-
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia